Search Results

691,041 Results for "synedgen inc".

Sort By

Biotech Beach

Synedgen Completes IND-Enabling Studies for Two Parallel Programs for Lead Asset MIIST305

Synedgen, Inc. announced it has completed IND-enabling studies for its lead candidate, MIIST305.

April 25, 2024
·
4 min read
Press Releases

Synedgen Adds Dr. Hal J. Oien to its Board of Directors

September 24, 2024
·
2 min read
Press Releases

Synedgen Announces $2.2 Million JWMRP Award for MIIST305 For Use as a Prophylactic Radiation Medical Countermeasure

November 1, 2024
·
4 min read
Press Releases

Synedgen Receives Contract from BARDA to Develop MIIST305 as a Medical Countermeasure for Gastrointestinal Acute Radiation Syndrome

October 15, 2024
·
4 min read
Press Releases

Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

January 23, 2025
·
5 min read
Press Releases

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor

February 3, 2025
·
7 min read
Press Releases

Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.

January 27, 2025
·
13 min read
Press Releases

Jabil Acquires Pharmaceutics International, Inc. (Pii)

February 4, 2025
·
4 min read
Business

Synedgen Appoints Industry Veteran Dennis Fenton, Ph.D., to Board of Directors

Synedgen, a biopharma company dedicated to using its Multivalent Innate Immune Signaling Target (MIIST) platform to develop drugs that mimic and enhance the innate immune system, today announced that industry veteran Dennis Fenton, Ph.D., has joined Synedgen’s Board of Directors.

February 18, 2021
·
2 min read
Press Releases

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

February 3, 2025
·
1 min read